相关实验视频
Updated: Feb 18, 2026

06:03
Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
Published on: June 11, 2020
9.8K
推进RNAi纳米疗法用于缺血性心脏病的发展
Han Gao1, Da Pan2, Hélder A Santos3
1Department of Pharmacology, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
Advanced materials (Deerfield Beach, Fla.)
|February 17, 2026
概括
RNA干扰 (RNAi) 纳米技术为心肌梗塞后的心脏修复提供了一个有前途的方法. 本综述探讨了用于治疗心脏病的RNAi纳米医学,重点关注治疗进展和未来的机会.
科学领域:
- 心血管医学和纳米技术
- 分子生物学和基因疗法
背景情况:
- 缺血性心脏病 (IHD) 是全球主要的死亡原因,心脏病发作后的再生能力有限.
- 传统疗法在有效治疗心肌损伤方面面临挑战.
研究的目的:
- 审查RNA干扰 (RNAi) 纳米药物用于心脏修复的不断变化的景观.
- 强调心肌梗塞和动脉样硬化的治疗进展.
- 讨论有效的RNAi纳米系统及其转化途径的设计考虑因素.
主要方法:
- 关于RNAi纳米医学在心血管治疗中的当前文献的综述.
- 对纳米系统构建的设计原则的分析,整合机械学见解和材料工程.
- 讨论从临床前研究到临床应用的转化途径.
主要成果:
- RNAi纳米技术提供了以序列为导向的基因调节,以克服心脏修复中的治疗障碍.
- 在应用RNAi纳米药物治疗心肌梗塞和动脉样硬化方面取得了重大治疗进展.
- 设计有效纳米系统的关键原则将机械学理解与材料科学联系起来.
结论:
- RNAi纳米医学代表了心血管治疗的革命性方法,为心脏修复提供了新的途径.
- 翻译这些先进的治疗方法需要解决目前在开发和临床应用方面的挑战.
- 未来的机遇在于优化纳米系统设计,并为广泛采用而导航从长椅到床边的途径.
相关概念视频
RNA Interference
28.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K
Experimental RNAi
7.8K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.8K
siRNA - Small Interfering RNAs
18.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.8K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.6K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.6K
Ischemic Heart Disease: Overview
3.5K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K
Types of RNA
9.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
9.9K

